I am having great success in helping patients that have HER+ mets to the brain. I suggest intrathecal traumuzumab and topotecan at therapeutic doses. Cancer centers have started to agree. Insurance pays for it. 94% remission rate. Send me email. No charge.
You must log in to use this feature, please click here to login.